Haque, Omar
Pendexter, Casie A.
Wilks, Benjamin T.
Hafiz, Ehab O. A.
Markmann, James F.
Uygun, Korkut
Yeh, Heidi
Tessier, Shannon N.
Funding for this research was provided by:
American Liver Foundation (2019 Hans Popper Memorial Postdoctoral Research Fellowship)
American College of Surgeons (1123-39991)
US National Institutes of Health (NSF ATP-Bio ERC grant (NSF 1941543))
US National Institutes of Health (R01DK096075)
US National Institutes of Health (R01DK114506)
US National Institutes of Health (R01DK107875)
American Heart Association (18CDA34110049)
Harvard Medical School Eleanor and Miles Shore Fellowship
Claflin Distinguished Scholar Award
Article History
Received: 28 July 2021
Accepted: 1 November 2021
First Online: 30 November 2021
Competing interests
: The authors declare competing interests. Drs. Uygun and Tessier have provisional patent applications relevant to this study. Dr. Uygun has a financial interest in Organ Solutions, a company focused on developing organ preservation technology. Drs. Uygun and Tessier serve on the Scientific Advisory Board for Sylvatica Biotech Inc., a company focused on developing new preservation technologies. All competing interests are managed by the MGH and Partners HealthCare in accordance with their conflict-of-interest policies. No other authors have any competing interests.